TsampasianVElghazalyHChattopadhyayR, et al.Risk factors associated with post−COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183(6):566-580. doi:10.1001/JAMAINTERNMED.2023.0750
8.
KhullarDZhangYZangC, et al.Racial/ethnic disparities in post-acute sequelae of SARS-CoV-2 infection in New York: an EHR-based cohort study from the RECOVER program. J Gen Intern Med. 2023;38(5):1127-1136. doi:10.1007/S11606-022-07997-1
PfaffERGirvinATBennettTD, et al.Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit Heal. 2022;4(7):e532-e541. doi:10.1016/S2589-7500(22)00048-6
11.
BanerjeeA. Disparities by social determinants of health: links between long COVID and cardiovascular disease. Can J Cardiol. 2024;40(6):1123-1134. doi:10.1016/j.cjca.2024.02.017
BoehmerTKKoumansEHSkillenEL, et al.Racial and ethnic disparities in outpatient treatment of COVID-19 ― United States, January–July 2022. MMWR Morb Mortal Wkly Rep. 2022;71(43):1359-1365. doi:10.15585/MMWR.MM7143A2
14.
XieYChoiTAl-AlyZ. Association of treatment with nirmatrelvir and the risk of post–COVID-19 condition. JAMA Intern Med. 2023;183(6):554-564. doi:10.1001/jamainternmed.2023.0743
15.
KachenAPharrJR. Health care access and utilization by transgender populations: a United States transgender survey study. Transgend Health. 2020;5(3):141-148. doi:10.1089/TRGH.2020.0017
16.
AuLCapotescuCEyalGFinestoneG. Long covid and medical gaslighting: dismissal, delayed diagnosis, and deferred treatment. SSM Qual Res Heal. 2022;2:100167. doi:10.1016/J.SSMQR.2022.100167
JavedZHaisum MaqsoodMYahyaT, et al.Race, racism, and cardiovascular health: applying a social determinants of health framework to racial/ethnic disparities in cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2022;15(1):e007917. doi:10.1161/CIRCOUTCOMES.121.007917
19.
BravemanPAArkinEProctorDKauhTHolmN. Systemic and structural racism: definitions, examples, health damages, and approaches to dismantling. Health Aff. 2022;41(2):171-178. doi:10.1377/HLTHAFF.2021.01394
20.
AlegríaMAranetaMRRiversB. The national advisory Council on minority health and health disparities reflection. Am J Public Health. 2019;109(Suppl 1):S14-S15. doi:10.2105/AJPH.2019.304961
21.
OwensB. Mapping biomedical research in the USA. Lancet. 2014;384(9937):11-14. doi:10.1016/S0140-6736(14)61114-4
The National Institutes of Health (NIH) funds studies to advance the understanding, diagnosis, and treatment of post-acute sequalae of SARS-CoV-2 (PASC), including Long COVID. [Review of the National Institutes of Health (NIH) funds studies to advance the understanding, diagnosis, and treatment of post-acute sequalae of SARS-CoV-2 (PASC), including Long COVID.]. RECOVER- Researching COVID to Enhance Recovery; National Institutes of Health. Retrieved September 5, 2024, from: https://recovercovid.org/funding
ByambasurenOStehlikPClarkJAlcornKGlasziouP. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023;2(1):e000385. doi:10.1136/bmjmed-2022-000385
28.
ThaweethaiTJolleySEKarlsonEW, et al.Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934-1946. doi:10.1001/JAMA.2023.8823
29.
GrossRSThaweethaiTKleinmanLC, et al.Characterizing long COVID in children and adolescents. JAMA. 2024;332:1174-1188. doi:10.1001/JAMA.2024.12747
30.
GanesanAArimondoPBRotsMGJeronimoCBerdascoM. The timeline of epigenetic drug discovery: from reality to dreams. Clin Epigenetics. 2019;11(1):174. doi:10.1186/S13148-019-0776-0
31.
KaplanKMendenhallE. Framing long Covid through patient activism in the United States: patient, provider, academic, and policymaker views. Soc Sci Med. 2024;350:116901. doi:10.1016/j.socscimed.2024.116901
32.
GardnerELockreyAStoesserKL, et al.Challenges in receiving care for long COVID: a qualitative interview study among primary care patients about expectations and experiences. Ann Fam Med. 2024;22:369-374. doi:10.1370/afm.3145
33.
National Academies of Sciences, Engineering, and Medicine. A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences. Washington, DC: The National Academies Press; 2024.
KhanSChambersDNetaG. Revisiting time to translation: implementation of evidence-based practices (EBPs) in cancer control. Cancer Causes Control. 2021;32:221-230. doi:10.1007/s10552-020-01376-z
36.
DavisHEAssafGSMcCorkellL, et al.Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi:10.1016/j.eclinm.2021.101019
37.
Al-AlyZXieYBoweB. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259-264. doi:10.1038/s41586-021-03553-9
38.
DavisHEMcCorkellLVogelJMTopolEJ. Author correction: long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133-146. doi:10.1038/s41579-022-00846-2
39.
ChouRHermanEAhmedA, et al.Long COVID definitions and models of care: a scoping review. Ann Intern Med. 2024;177:929-940. doi:10.7326/M24-0677
40.
KarpmanMZuckermanSMorrissS. Health care access and affordability among US adults aged 18 to 64 years with self-reported post-COVID-19 condition. JAMA Netw Open. 2023;6(4):e237455. doi:10.1001/jamanetworkopen.2023.7455
PikeJKompaniyetsLLindleyMCSaydahSMillerG. Direct medical costs associated with post–COVID-19 conditions among privately insured children and adults. Prev Chronic Dis. 2023;20:E06. doi:10.5888/pcd20.220292
Department of Health and Human Services, Office of the Assistant Secretary for Health. Services and supports for longer-term impacts of COVID-19, 200 Independence Ave SW, Washington, DC 20201. 2022.
56.
FisherKAMazorKMEpsteinMM, et al.Long COVID awareness and receipt of medical care: a survey among populations at risk for disparities. Front Public Health. 2024;12:1360341. doi:10.3389/fpubh.2024.1360341
MacMonegleAJNonnemakerJDukeJC, et al.Cost-effectiveness analysis of the real cost campaign’s effect on smoking prevention. Am J Prev Med. 2018;55(3):319-325. doi:10.1016/J.AMEPRE.2018.05.006
60.
ShresthaSSDavisKMannN, et al.Cost effectiveness of the tips from former smokers® campaign-U.S., 2012-2018. Am J Prev Med. 2021;60(3):406-410. doi:10.1016/j.amepre.2020.10.009
DenisonBDahlenHKimJEC, et al.Evaluation of the “we can do this” campaign paid media and COVID-19 vaccination uptake, United States, December 2020-January 2022. J Health Commun. 2023;28(9):573-584. doi:10.1080/10810730.2023.2236976
63.
TurnerSKranzlerECTriggerS, et al.Benefit-cost analysis of the HHS COVID-19 campaign: April 2021-March 2022. Am J Prev Med. 2024;67(2):258-264. doi:10.1016/j.amepre.2024.03.018
64.
EitzeSSprengholzPKornLShamsriziPFelgendreffLBetschC. Vicarious experiences of long COVID: a protection motivation theory analysis for vaccination intentions. Vaccine X. 2023;16:100417. doi:10.1016/j.jvacx.2023.100417